Company profile
Ticker
QDEL
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Coronado Topco, Inc.
SEC CIK
Corporate docs
Subsidiaries
Ortho-Clinical Diagnostics Australia Pty Ltd. • Ortho-Clinical Diagnostics GmbH • Ortho-Clinical Diagnostics FinCo S.a.r.l. • Ortho-Clinical Diagnostics NV • Ortho Clinical Diagnostics Do Brasil Produtos Para Saude Ltda. • 10165 McKellar Court, L.P. • Immutopics, Inc. • QuidelOrtho Canada Corporation • Quidel China, Ltd. • Ortho-Clinical Diagnostics Trading (China) Co. Ltd. ...
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
2 Apr 24
DEFA14A
Additional proxy soliciting materials
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
8-K/A
Departure of Directors or Certain Officers
29 Feb 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Departure of Directors or Certain Officers
21 Feb 24
8-K
Regulation FD Disclosure
16 Feb 24
8-K
QuidelOrtho Reports Fourth Quarter and Full-Year 2023
13 Feb 24
8-K
Departure of Directors or Certain Officers
1 Dec 23
10-Q
2023 Q3
Quarterly report
1 Nov 23
Latest ownership filings
Financial summary
Quarter (USD) | Oct 23 | Jul 23 | Apr 23 | Jan 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jan 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 149.90 mm | 149.90 mm | 149.90 mm | 149.90 mm | 149.90 mm | |
Cash burn (monthly) | 9.90 mm | 5.28 mm | (no burn) | (no burn) | (no burn) | |
Cash used (since last report) | 67.43 mm | 35.93 mm | n/a | n/a | n/a | |
Cash remaining | 82.47 mm | 113.97 mm | n/a | n/a | n/a | |
Runway (months of cash) | 8.3 | 21.6 | n/a | n/a | n/a |
Institutional ownership, Q3 2023
96.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 301 |
Opened positions | 38 |
Closed positions | 46 |
Increased positions | 77 |
Reduced positions | 134 |
13F shares | Current |
---|---|
Total value | 4.60 tn |
Total shares | 64.66 mm |
Total puts | 373.60 k |
Total calls | 486.40 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
CG Carlyle Group Inc | 12.46 mm | $910.09 bn |
T. Rowe Price Investment Management | 6.97 mm | $509.22 bn |
BLK Blackrock | 4.81 mm | $351.68 bn |
Vanguard | 4.80 mm | $350.35 bn |
Senvest Management | 3.33 mm | $243.24 bn |
ArrowMark Colorado | 3.14 mm | $229.61 bn |
Neuberger Berman | 1.62 mm | $118.56 bn |
STT State Street | 1.47 mm | $107.38 bn |
Burgundy Asset Management | 1.35 mm | $98.61 bn |
JPM JPMorgan Chase & Co. | 1.27 mm | $92.90 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Apr 24 | Buechler Kenneth F | Common Stock | Option exercise | Acquire M | No | No | 21.07 | 9,041 | 190.49 k | 83,679 |
12 Apr 24 | Buechler Kenneth F | NQSO Common Stock | Option exercise | Dispose M | No | No | 21.07 | 9,041 | 190.49 k | 0 |
28 Mar 24 | Michelle A. Hodges | Common Stock | Payment of exercise | Dispose F | No | No | 47.94 | 879 | 42.14 k | 13,441 |
28 Mar 24 | Michelle A. Hodges | Common Stock | Grant | Acquire A | No | No | 0 | 2,462 | 0.00 | 14,320 |
28 Mar 24 | Michelle A. Hodges | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,462 | 0.00 | 4,926 |
28 Mar 24 | Bujarski Robert Joseph | Common Stock | Payment of exercise | Dispose F | No | No | 47.94 | 2,805 | 134.47 k | 44,500 |
28 Mar 24 | Bujarski Robert Joseph | Common Stock | Grant | Acquire A | No | No | 0 | 4,925 | 0.00 | 47,305 |
28 Mar 24 | Bujarski Robert Joseph | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 4,925 | 0.00 | 9,850 |
28 Mar 24 | Kroll Werner | Common Stock | Payment of exercise | Dispose F | No | No | 47.94 | 1,801 | 86.34 k | 35,781 |
28 Mar 24 | Kroll Werner | Common Stock | Grant | Acquire A | No | No | 0 | 3,811 | 0.00 | 37,582 |
News
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
2 Apr 24
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
2 Apr 24
QuidelOrtho Receives FDA Clearance For QuickVue COVID-19 Test
2 Apr 24
Analyst Scoreboard: 6 Ratings For QuidelOrtho
4 Mar 24
UBS Downgrades QuidelOrtho to Sell, Lowers Price Target to $42
4 Mar 24
Press releases
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against QuidelOrtho Corporation – QDEL
24 Apr 24
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm
24 Apr 24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, and Sharecare and Encourages Investors to Contact the Firm
23 Apr 24
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm
23 Apr 24
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous Q4 2023 Results, Terminates CEO, Withdraws FDA Submission - Hagens Berman
22 Apr 24